บุคลากรคณะวิทยาศาสตร์
Help Center
ต้องการปรับปรุงข้อมูลบุคลากร ติดต่องานบริหารทรัพยากรมนุษย์ (8015) (siriporn.t@psu.ac.th)
ต้องการปรับปรุงข้อมูล Publication ติดต่องานสนับสนุนการวิจัย (8079) (thanapat.s@psu.ac.th)
ผศ.ดร.
สุมาลี อบเชย
ผู้ช่วยศาสตราจารย์
Fellow (UKPSF)
- sumalee.o@psu.ac.th
- 8270
- ชีวเคมี
- สาขาวิทยาศาสตร์สุขภาพและวิทยาศาสตร์ประยุกต์
ประวัติการศึกษา
ปีที่สำเร็จการศึกษา
วุฒิการศึกษา
ประเทศ
2554
ปร.ด. (ชีวเคมีทางการแพทย์) มหาวิทยาลัยขอนแก่น
ไทย
2549
วท.บ. (เทคนิคการแพทย์) มหาวิทยาลัยขอนแก่น
ไทย
Publication
ฐานข้อมูล Scopus
Author ID: 35503734500
1
Pratummanee K., Kerdkumthong K., Roytrakul S., Tantimetta P., Runsaeng P., Saeheng S., Obchoei S., 2024. Knockdown of cullin 3 inhibits progressive phenotypes and increases chemosensitivity in cholangiocarcinoma cells. Molecular Medicine Reports 30(5) (cited 0 times)
2
Pantong W., Somsap O.A., Kamnate A., Ekchaweng K., Obchoei S., Saeheng S., 2024. Analyzing the Antibacterial, Anticancer, and Antioxidant Qualities of the Stink Bean (Parkia Speciosa) by Various Extraction Techniques. Trends in Sciences 21(9) (cited 0 times)
3
Kerdkumthong K., Roytrakul S., Songsurin K., Pratummanee K., Runsaeng P., Obchoei S., 2024. Proteomics and Bioinformatics Identify Drug-Resistant-Related Genes with Prognostic Potential in Cholangiocarcinoma. Biomolecules 14(8) (cited 1 times)
4
Kerdkumthong K., Nanarong S., Roytrakul S., Pitakpornpreecha T., Tantimetta P., Runsaeng P., Obchoei S., 2024. Quantitative proteomics analysis reveals possible anticancer mechanisms of 5’-deoxy-5’-methylthioadenosine in cholangiocarcinoma cells. PLoS ONE 19(6 June) (cited 1 times)
5
Kerdkumthong K., Chanket W., Runsaeng P., Nanarong S., Songsurin K., Tantimetta P., Angsuthanasombat C., Aroonkesorn A., Obchoei S., 2024. Two Recombinant Bacteriocins, Rhamnosin and Lysostaphin, Show Synergistic Anticancer Activity Against Gemcitabine-Resistant Cholangiocarcinoma Cell Lines. Probiotics and Antimicrobial Proteins 16(3): 713-725. (cited 2 times)
6
Saengboonmee C., Obchoei S., Sawanyawisuth K., Wongkham S., 2023. Revision of potential prognostic markers of cholangiocarcinoma for clinical practice. Expert Review of Anticancer Therapy 23(5): 517-530. (cited 0 times)
7
Madsari N., Maskaew S., Obchoei S., Kwankaew P., Senghoi W., Utarabhand P., Runsaeng P., 2022. Determination of the efficacy of using a serine protease gene as a DNA vaccine to protect against Vibrio parahaemolyticus infection in Litopenaeus vannamei. Developmental and Comparative Immunology 135 (cited 3 times)
8
Obchoei S., Detarya M., Boonnate P., Saranaruk P., Vaeteewoottacharn K., Mahalapbutr P., Okada S., Wongkham S., 2022. Low Dose Berberine Suppresses Cholangiocarcinoma Cell Progression as a Multi-Kinase Inhibitor. Asian Pacific Journal of Cancer Prevention 23(10): 3379-3386. (cited 3 times)
9
Kotepui K.U., Obchoei S., Vaeteewoottacharn K., Okada S., Wongkham S., Sawanyawisuth K., 2022. Annexin A1 Is a Potential Prognostic Marker for, and Enhances the Metastasis of, Cholangiocarcinoma. Asian Pacific Journal of Cancer Prevention 23(2): 715-721. (cited 2 times)
10
Klinhom-on N., Seubwai W., Sawanyawisuth K., Obchoei S., Mahalapbutr P., Wongkham S., 2021. FOXM1 inhibitor, Siomycin A, synergizes and restores 5-FU cytotoxicity in human cholangiocarcinoma cell lines via targeting thymidylate synthase. Life Sciences 286 (cited 10 times)
Content provided by Scopus.
Publication
ฐานข้อมูลคณะวิทยาศาสตร์
1
Kerdkumthong, K., Roytrakul, S., Songsurin, K., & Obchoei, S. (2024). Proteomics and Bioinformatics Identify Drug-Resistant-Related Genes with Prognostic Potential in Cholangiocarcinoma (SCIE). Biomolecules, 14(8), Biomolecules.
2
Pratummanee, K., Kerdkumthong, K., Roytrakul, S., Tantimetta, P., Runsaeng, P., Saeheng, S., & Obchoei, S. (2024). Knockdown of cullin 3 inhibits progressive phenotypes and increases chemosensitivity in cholangiocarcinoma cells (SCIE). Molecular Medicine Reports, 30(5), Article number 198.
3
Kerdkumthong, K., Nanarong, S., Roytrakul, S., Pitakpornpreecha, T., Tantimetta, P., Runsaeng, P., & Obchoei, S. (2024). Quantitative proteomics analysis reveals possible anticancer mechanisms of 5’-deoxy-5’-methylthioadenosine in cholangiocarcinoma cells (SCIE). Plos One, 19(6), Article number e0306060.
4
Kerdkumthong, K., Chanket, W., Runsaeng, P., Nanarong, S., Songsurin, K., Tantimetta, P., Angsuthanasombat, C., Aroonkesorn, A., & Obchoei, S. (2023). Two Recombinant Bacteriocins, Rhamnosin and Lysostaphin, Show Synergistic Anticancer Activity Against Gemcitabine-Resistant Cholangiocarcinoma Cell Lines (SCIE). Probiotics And Antimicrobial Proteins, 00, 00.
5
Saengboonmee, C., Obchoei, S., Sawanyawisuth, K., & Wongkham, S. (2023). Revision of potential prognostic markers of cholangiocarcinoma for clinical practice (SCIE). Expert Review Of Anticancer Therapy, 23(5), 517-530.
6
Obchoei, S., Detarya, M., Boonnate, P., Saranaruk, P., Vaeteewoottacharn, K., Mahalapbutr, P., Okada, S., & Wongkham, S. (2022). Low Dose Berberine Suppresses Cholangiocarcinoma Cell Progression as a Multi-Kinase Inhibitor. Asian Pacific Journal Of Cancer Prevention : Apjcp, 23(10), 3379 - 3386.
7
Madsari, N., Maskaew, S., Obchoei, S., Kwankaew, P., Senghoi, W., Utarabhand, P., & Runsaeng, P. (2022). Determination of the efficacy of using a serine protease gene as a DNA vaccine to protect against Vibrio parahaemolyticus infection in Litopenaeus vannamei (SCIE)
. Developmental And Comparative Immunology, 135, Article number 104459.
8
U Kotepui, K., Obchoei, S., Vaeteewoottacharn, K., Okada, S., Wongkham, S., & Sawanyawisuth, K. (2022). Annexin A1 Is a Potential Prognostic Marker for, and Enhances the Metastasis of, Cholangiocarcinoma. Asian Pacific Journal Of Cancer Prevention, 23(2), 715 - 721.
9
Klinhom-on, N., Seubwai, W., Sawanyawisuth, K., Obchoei, S., Mahalapbutr, P., & Wongkham, S. (2021). FOXM1 inhibitor, Siomycin A, synergizes and restores 5-FU cytotoxicity in human cholangiocarcinoma cell lines via targeting thymidylate synthase (SCIE). Life Sciences, 286, Article number 120072.
10
Dana, P., Saisomboon, S., Kariya, R., Okada, S., Obchoei, S., Sawanyawisuth, K., Wongkham, C., Pairojkul, C., Wongkham, S., & Vaeteewoottacharn, K. (2020). CD147 Augmented Monocarboxylate transporter-1/4 Expression Through Modulation of the Akt-FoxO3-NF-κB Pathway Promotes Cholangiocarcinoma Migration and Invasion. Cellular Oncology, 43(2), 211-222.